Revolution Medicines, Inc. (NASDAQ:RVMDW) Short Interest Update

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the target of a significant drop in short interest during the month of October. As of October 31st, there was short interest totalling 4,700 shares, a drop of 66.2% from the October 15th total of 13,900 shares. Based on an average daily volume of 34,800 shares, the short-interest ratio is presently 0.1 days.

Revolution Medicines Trading Down 9.8 %

Shares of NASDAQ:RVMDW traded down $0.06 on Tuesday, hitting $0.55. 11,246 shares of the company were exchanged, compared to its average volume of 18,419. The stock’s 50 day moving average price is $0.18 and its 200 day moving average price is $0.17. Revolution Medicines has a 1-year low of $0.03 and a 1-year high of $1.05.

About Revolution Medicines

Revolution Medicines, Inc, a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies.